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Abstract 
 
 
HDLs protect pancreatic beta cells against apoptosis induced by several endoplasmic reticulum (ER) 
stressors, including thapsigargin, cyclopiazonic acid, palmitate and insulin over-expression. This 
protection is mediated by the capacity of HDLs to maintain proper ER morphology and ER functions such 
as protein folding and trafficking. Here, we identified a distinct mode of protection exerted by HDLs in beta 
cells challenged with tunicamycin (TM), a protein glycosylation inhibitor inducing ER stress. HDLs were 
found to inhibit apoptosis induced by TM in the Min6 insulinoma cell line and this correlated with the 
maintenance of a normal ER morphology. Surprisingly however, this protective response was neither 
associated with a significant ER stress reduction, nor with restoration of protein folding and trafficking in 
the ER. These data indicate that HDLs can use at least two mechanisms to protect beta cells against ER 
stressors. One that relies on the maintenance of ER function and one that operates independently of ER 
function modulation. The capacity of HDLs to activate several anti-apoptotic pathways in beta cells may 
explain their ability to efficiently protect these cells against a variety of insults. 
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1. Introduction 
 
 
Low HDL level in the blood is an independent risk factor of developing diabetes (Rohrer et al., 2004; von 
Eckardstein et al., 2000). This indicates that HDLs have beneficial effects on the insulin-producing 
pancreatic beta cells and/or on the peripheral tissues that respond to insulin. Indeed, studies performed in 
humans indicate that HDLs increase beta cell insulin secretory function and glucose utilization of muscle 
cells (Drew et al., 2009). The beneficial effects of HDLs on beta cells are multiple. They increase their 
insulin secretory capacity (Fryirs et al., 2010) and they protect them against apoptosis induced by a variety 
of stress and noxious stimuli, including oxidized LDLs (Abderrahmani et al., 2007; Cnop et al., 2002), 
starvation (Petremand et al., 2009), inflammatory cytokines (Petremand et al., 2009; Rutti et al., 2009), 
and ER stress (Petremand et al., 2009; Petremand et al., 2012; Rutti et al., 2009). 
 
The HDL-mediated protective mechanisms have been investigated in details in endothelial cells. HDL- 
mediated signaling in endothelial cells can occur through binding to the lipoprotein receptor scavenger 
receptor class B member I (SR-BI) and activation of G protein-coupled receptors of the Edg family that 
bind to sphingosine-1-phosphate molecules carried by HDL particles (Al-Jarallah and Trigatti, 2010; 
Kimura et al., 2010; Nofer et al., 2004). Incubation of endothelial cells with HDL leads to activation of the 
Akt anti-apoptotic kinase (Nofer et al., 2001). Although not formally demonstrated, stimulation of the SR- 
BI/Edg signaling pathway is believed to mediate Akt activation in HDL-stimulated endothelial cells. The 
anti-apoptotic pathways activated by HDLs in pancreatic beta cells appear different. There is currently no 
evidence that HDLs activate Akt in beta cells. Additionally, SR-BI does not participate in HDL-mediated 
beta cell protection (Petremand et al., 2012; Rutti et al., 2009; von Eckardstein and Sibler, 2011). 
 
 
Pancreatic beta cells rely on their extensively developed ER to fulfill their main function which is to secrete 
insulin. If ER homeostasis is perturbed, for example as a result of increased insulin secretion demand or in 
response to free fatty acids (e.g. palmitate), ER stress ensues and this can lead to beta cell apoptosis, 
and eventually, in vivo, to diabetes development (Eizirik et al., 2008; Eizirik and Cnop, 2010). 
  
 
 
The unfolded protein response is induced physiologically by cells experiencing ER stress. The goal of this 
response is to restore ER homeostasis. This is mediated by diminishing the ER load by reducing protein 
synthesis and by increasing the folding capacity of the ER and the degradation of misfolded protein. If 
despite these responses ER homeostasis cannot be achieved, the UPR activates pro-apoptotic pathways 
so that the cells with malfunctioning ER are eliminated. The UPR consists in the activation of three 
different signaling arms that regulate distinct as well as overlapping set of genes (reviewed in (Hetz, 
2012). These different pathways are stimulated when three ER-located proteins, inositol-requiring protein 
1 (IRE1), activating transcription factor 6 (ATF6), and protein kinase RNA-like ER kinase (PERK) become 
activated upon ER stress. Activated IRE1 induces the splicing of the XBP1 mRNA so that it encodes a 
functional transcription factor. IRE1 can also lead to the stimulation of the JNK MAPK pathway. PERK is a 
kinase that phosphorylates the initiation factor eukaryotic translation initiator factor 2α(eIF2α), which is then 
hampered in its capacity to mediate global translation but which at the same time acquires the ability to 
mediate the translation of a few selected proteins such as ATF4. Finally, ATF6 is a transcription factor that 
moves from the ER to the Golgi where it is activated by cleavage and then translocates to the nucleus. 
The UPR regulates genes encoding BiP, a protein chaperone and CHOP, a pro-apoptotic transcription 
factor (Hetz, 2012) 
 
Recently, the capacity of HDLs to inhibit apoptosis induced by ER stressors such as palmitate or the 
SERCA inhibitor thapsigargin (TG) has been attributed to their ability to preserve normal morphology and 
functionality of the ER (Petremand et al., 2012). In particular, HDLs permit beta cells to maintain normal 
protein folding in the ER and correct protein trafficking through this organelle despite the presence of ER 
stressors (Petremand et al., 2012). Here we show that HDLs are able to inhibit apoptosis of beta cells 
induced by tunicamycin, a protein glycosylation inhibitor, known to induce ER stress (Petremand et al., 
2009). Surprisingly, this protection was neither associated with a reduction in ER stress nor with 
restoration of protein folding and trafficking in the ER. There are therefore situations where HDLs inhibit 
ER stress-induced apoptosis in conditions where the ER stress is not alleviated. This indicates that HDLs 
can use alternative ways than preservation of ER function to protect beta cells facing ER stress. 
  
 
 
 
 
 
2. Materials and Methods 
 
 
 
2.1. Chemicals 
 
Tunicamycin and thapsigargin were purchased from Sigma (catalog n°T7765 and T9033, respectively). 
The nondenaturing Zwitterionic detergent 3-[(3-cholamidopropyl)dimethylammonio]-1 propanesulfonate 
(CHAPS) was from Fluka (catalog n°26680). Palmitate was prepared as described earlier (Petremand et 
al., 2012). 
 
 
2.2. Cell culture 
 
The MIN6B1 mouse insulinoma cell line (referred here as MIN6) was maintained in DMEM, 25 mM 
glucose, supplemented with 15% fetal calf serum (FCS), 1% sodium pyruvate, 83 μM β-mercaptoethanol. 
In experiments using MIN6, cells were plated in six-well plates at a density of 0.5 million cells per well and 
cultured for 2 days before treatment; alternatively, when glass cover slips were added in the six-well 
plates, 0.3 million cells were seeded per well and cultured for 3 days before treatments. 
 
 
2.3. Western Blot 
 
Insulinoma cells were lysed in monoQ-c [70 mM β-glycerophosphate, 0.5% Triton X-100, 2 mM MgCl2, 1 
mM EGTA, 100 µM Na3VO4, 1 mM dithiothreitol, 20 µg/ml aprotinin, complete EDTA-free Protease 
Inhibitor Cocktail Tablets (Roche; 1 tablet per 50 ml) and incubated 15 minutes on ice. The lysate was 
spun in an Eppendorf centrifuge for 10 minutes at full speed at 4°C and the cleared lysate was then 
recovered. 
Proteins were separated on SDS-PAGE and blotted onto nitrocellulose membranes (BioRad, catalog 
n°1620115). Thereafter, membranes were incubated in TBS (18 mM HCl, 130 mM NaCl, 20 mM Tris), 
0.1% Tween 20 (Acros Organics; catalog n°233362500) (TBS-T) and 5% milk (v:v) for one hour at room 
temperature and then incubated overnight with the appropriate primary antibody. 
  
 
 
The primary antibodies used in TBS-T 5% milk were the following: anti-CHOP (Santa Cruz; catalog 
n°7351) diluted 1:500, anti-actin (Cell Signaling, catalog n° 4968) diluted 1:5000, anti-Bax (N-20 from 
Santa Cruz, catalog n°493 diluted 1/1000. 
The following primary antibodies were all diluted 1:1’000 (unless otherwise indicated) in TBS-T containing 
5% BSA (v:v): anti-BiP (=GRP78, Santa Cruz, catalog n°13968) diluted 1:500, anti-caspase-3 (Cell 
Signaling, catalog n°9661), anti-phospho-PERK (Cell Signaling, catalog n° 3179), anti phospho-Akt mouse 
monoclonal antibody (Ser473) (Cell Signaling, catalog n° 4051), anti phospho-SAPK/JNK (Thr183/Tyr185) 
rabbit polyclonal antibody (Cell Signaling, catalog n° 9251), anti-pan Akt rabbit monoclonal 11E7 antibody 
(Cell Signaling, catalog n° 4685), and anti-SAPK/JNK rabbit monoclonal 56G8 antibody (Cell Signaling, 
catalog n° 9258). 
After rinsing the membrane in PBS, the secondary antibodies used were IRDye 800-conjugated goat anti- 
rabbit IgG (Rockland, catalog n°611-132-122), IRDye 800-conjugated goat anti-mouse IgG (Rockland, 
catalog n°610-132-121), Alexa Fluor 680-conjugated goat anti-rabbit IgG (Molecular Probes, catalog 
n°A21109) or Alexa Fluor 680-conjugated goat anti-mouse IgG (Molecular Probes, catalog n°A21058) all 
diluted 1:5000 in blocking solution (TBS-T with milk). For phospho-PERK, anti-rabbit HRP (Jackson 
Immunoresearch Laboratories, catalog n° 211-035-109) diluted 1:10000 was used. Membranes were 
washed in TBS-T after incubation with the first and the second antibodies. Visualization was performed 
using the Odyssey infrared imaging device and software (Licor, Hamburg, Germany). 
 
 
2.4. Apoptosis 
 
Apoptosis of MIN6 cells was determined by scoring the  number  of  cells  displaying  pycnotic  and/or 
fragmented nucleus after fixation in PBS, 2% paraformaldehyde and staining with Hoechst 33342 (floating 
apoptotic cells were included). 
 
 
2.5. Bax immunoprecipitation 
 
MIN6 cells were lysed in 500 µl CHAPS buffer [1% CHAPS, 10 mM Hepes pH 7,4, 150 mM NaCl]. The 
lysates (700 µg) were incubated with 1.5 μl of the 6A7 Bax monoclonal antibody recognizing the active 
form of Bax (Santa Cruz, catalog n°23959) overnight with gentle rotation. The next day, 10 µl of protein G- 
sepharose beads were added and the incubation resumed for 2 additional hours. The beads were then 
 
 
washed three times with CHAPS buffer, mixed with loading buffer, boiled and loaded on a gel for 
subsequent Western blot analysis. 
 
 
2.6. Immunocytochemistry 
 
Cells on coverslips were washed with PBS, fixed with PBS, 2% paraformaldehyde and stained with 2.5 
mg/ml Hoechst 33342. Following washing with PBS, the cells were permeabilized with 0.2 % (v:v) Triton 
X-100 in PBS for 10 minutes. The cells were then incubated in 10% FCS-containing DMEM for at least 20 
minutes and incubated one hour with various primary antibodies: the 1E9 monoclonal antibody (called I14 
in Lefrancois and Lyles, 1982) recognizing the correctly folded form of vesicular stomatatis virus 
glycoprotein (VSVG) (diluted 1:200), the 17-2-21-4 monoclonal antibody recognizing the VSVG 
protein exoplasmic domain (diluted 1:100), and the mouse IgG1κmonoclonal antibody specific for GM130 
(Golgi 
matrix protein of 130 kDa) (BD Biosciences, catalog n°610822) (diluted 1:500). After a washing step in 
PBS, the cells were incubated with a Cy3-conjugated donkey anti-mouse IgG (Jackson Immunoresearch, 
catalog n°715-165-151) diluted 1:200 in 10% FCS-containing DMEM one hour at room temperature. 
Finally, 6 washes in PBS over a 6 hour period were performed before mounting the coverslips in mounting 
medium for fluorescence [either Vectashield from Vector laboratories, catalog n° H1000 or 0.1 g/ml 
Mowiol, 0.22% (v/v) glycerol, Tris 0.1 M pH 8.5, 0.1% diazobicyclo-octane]. Images were acquired using a 
Nikon Eclipse 90i microscope. 
 
 
2.7. RNA extraction 
 
RNA was extracted by lysing cells, which were initially seeded at a density of 0.5 million cells per well in 
six-well plates and cultured 2 days, with 500 μl TRI buffer (1.7 M guanidinium thiocyanate, 0.1 M sodium 
citrate, 0.25% sarcosyl, 0.05 M β-mercaptoethanol, 0.1 M sodium acetate). Chloroform was then added 
(200 μl) and the lysates were vortexed. The samples were spun 15 min at maximum speed in an 
Eppendorf centrifuge and the aqueous phase transferred into a new tube containing 500 μl of 
isopropanol. The tubes were vortexed and kept at -20°C overnight. After spinning 20 min at maximum 
speed, isopropanol was aspirated and the pellets were washed with 800 μl ethanol 70% before being 
dried 5-10 
min at 50°C. Pellets were resuspended in 50 μl of high-quality water and RNA was quantitated using a 
 
 
NanoDrop device (NanoDrop 2000c, Thermo Fisher Scientific). Alternatively RNA was extracted using 
the High pure RNA Isolation Kit from Roche (catalog n°11828665001). 
 
 
2.8. Reverse transcription 
 
For reverse transcription, 0.5 μg of RNA was mixed with 500 ng of random hexamers (ordered from 
Microsynth, Balgach, Switzerland) in a total volume of water of 11 µl, incubated 3 minutes at 70°C and 
then placed on ice for 3 minutes. To this, 14 μl of a mix was added that contained 5 μl of a 10 mM dNTPs 
solution (Promega catalog n° U120D- U123D), 0.5 μl of RNasin (Promega, catalog n°N211A), 5 μl of 
buffer 5x, 2 μl DTT, 0.5 μl Superscript reverse transcriptase and 1 μl of water, everything provided in the 
Superscript II reverse Transcriptase Kit (Invitrogen, catalog n°18064-014). After incubation at 39°C for 1 
hour followed by 15 minutes at 70°C, the cDNA was diluted 1:3. Alternatively, reverse transcription was 
performed using the Transcriptor High Fidelity cDNA Synthesis Kit from Roche (catalog n°05 091 284 
001). 
 
 
2.9. Quantitative PCR 
 
qPCR assays were carried out on a real-time PCR detection system (iQ5; Bio-Rad) using iQ SYBR Green 
Supermix (Bio-Rad, catalog n°170-8880) using 100 nM primers, 1 μl of template (reverse transcription 
samples [see section above] diluted 1:3 in water) per 20 μl of PCR and an annealing temperature of 59°C. 
Melting curve analyses were performed on all PCRs to rule out non-specific amplification. Reactions were 
carried out in triplicates. The following primers were used: RPLP0 sense (5’- 
ACCTCCTTCTTCCAGGCTTT-3’) and antisense (5’-AAAGACTGGAGACAAGGTGG-3’), 18S sense (5’- 
GCAATTATTCCCCATGAACG-3’) and antisense (5’-GGCCTCACTAAACCATCCAA-3’), CHOP sense (5’- 
TTCACTACTCTTGACCCTGCGTC-3’) and antisense (5’-CACTGACCACTCTGTTTCCGTTTC-3’), spliced 
XBP1 sense (GAGTCCGCAGCAGGTG) and antisense (GTGTCAGAGTCCATGGGA), total XBP1 sense 
(AAGAACACGCTTGGGAATGG) and antisense (ACTCCCCTTGGCCTCCAC). 
 
 
2.10. XBP1 mRNA splicing 
Touchdown PCRs were performed using XBP1 sense (5’-AAACAGAGTAGCAGCGCAGACTGC-3’) and 
 
 
antisense (5’-GGATCTCTAAAACTAGAGGCTTGGTG-3’) primers and the Taq polymerase from Promega 
(catalog n°M830B). PCR products were loaded on a 4% agarose gel and run for about 6 hours to 
discriminate the 26 nucleotides difference between the expected spliced and unspliced forms. Two bands 
were generated in addition to the lower band that corresponds to the spliced XBP1 mRNA (see Figure 2, 
panel A). To determine which one of the two upper bands was non-specifically amplified, the PCR 
products were digested with PstI and run on a 4% gel for 1 hour. The PCR fragment amplified from the 
unspliced XBP1 mRNA contains a PstI restriction site more or less in its middle. When cleaved, this 
fragment should therefore disappear from the region where ~600 bp fragments migrate to. The band 
labeled with # in Figure 1A was not cleaved by PstI and is therefore an unspecific fragment. 
 
 
2.11. Lentivirus 
 
HEK293T cells were co-transfected using the calcium phosphate DNA precipitation method (Jordan et al., 
1996) with 10 µg of the lentiviral vector containing the shRNA or the cDNA of interest, 2.5 µg of the 
envelope protein–coding plasmid (pMD.G), and 7.5 µg of the packaging construct (pCMVDR8.91). Two 
days later, the virus-containing medium was harvested. Infection of the cells was performed as follows. 
Hexadimethrine bromide (Polybrene; Sigma, catalog n°52495) was added to cells cultured in six-well 
plates to a final concentration of 5 µg/ml followed by the addition of the lentiviruses. The plates were 
placed 24 hours at 37°C in a 5% CO2 humidified atmosphere. The medium was then replaced with fresh 
medium, and the cells were further cultured for an additional 48-hour period. 
 
 
 
2.12. Folding assay 
 
MIN6 cells were plated on coverlips and infected with 2.5 ml of a VSVG-GFP encoding lentivirus. Two 
days later, the cells were treated as mentioned in the figure legend. Cells were then fixed and cells on 
coverslips were labeled by immunocytochemistry. 
 
 
2.13. Lipoprotein preparation and 
purification 
 
HDLs were prepared as described earlier (Petremand et al., 2012). 
  
 
 
 
 
2.14. Plasmids 
 
Plasmid tsVSVG-GFP.lti (#730) is a lentiviral expression vector encoding a fusion protein between the 
temperature sensitive ts045 variant of vesicular stomatitis virus G protein (Presley et al., 1997) and GFP 
(Petremand et al., 2012). 
 
 
2.15. Electron microscopy 
 
MIN6 cells were plated in poly-L-lysine (0.01%, Sigma, catalog n°P4832)-coated glass slides (LabTek 
Chamber Slides, catalog n°177399) at a density of 110’000 cells per slide (area = 1.8 cm2), cultured for 3 
days, and finally treated as indicated in the figures. Cells were then fixed 2 hours in 2.5% glutaraldehyde 
(Electron Microscopy Sciences, catalog n°16220) dissolved in 0.1 M phosphate buffer (PB), pH 7.4. After 
3 washes in PB, MIN6 cells were post-fixed for 1 hour in 1% osmium tetroxide (Electron Microscopy 
Sciences, catalog n°19150) in PB, and then stained with ethanol 70% containing 1% uranyl acetate 
(Sigma, catalog n°73943) for 20 minutes. MIN6 cells were dehydrated in graded alcohol series and 
embedded in Epon (Electron Microscopy Sciences, catalog n°13940). Ultrathin sections (with silver to 
gray interference) were cut with a diamond knife (Diatome), mounted on Formvar-coated single slot grids 
and then counterstained with 3% uranyl acetate for 10 minutes and then with lead citrate (0.2%, Sigma, 
catalog n°15326) for 10 minutes. Sections were visualized using a Philips CM100 transmission electron 
microscope. 
 
 
2.16. Quantification of the ER thickness 
 
To evaluate the effect of the treatments on the ER integrity, the ER thickness was evaluated following 
each treatment. To do so, for each cell, the averaged thickness of ER per cell (i.e. the mean of the 
thickness of 20 ER figures per cell) was calculated. For each ER figure, the relative thickness was defined 
as the ratio between the area of the ER element and its Feret’s diameter. The Feret’s diameter, also called 
the caliper length, is the longest distance between any two points along a region of interest boundary. The 
area and the Feret’s diameter were measured using the Image J software. The results shown for each 
condition represent the mean of 50 cells. 
  
 
 
 
 
2.17. Data presentation and statistics 
 
The data in the figures are presented as the mean ± 95% confidence intervals. Statistical significance in 
Figures 4-7 was assessed by one-way ANOVA with post-hoc Bonferroni-Dunn testing. In Figure 3, the 
data were not following a normal distribution and were thus analyzed using a Kruskal-Wallis one-way 
ANOVA and unpaired Wilcoxon tests with Bonferroni correction. 
  
 
 
 
 
 
3. Results 
 
 
 
 
 
3.1. HDLs protect Min6 cells against tunicamycin-induced apoptosis 
 
 
HDLs have been shown to protect pancreatic beta cells against death induced by various ER stressors 
(Petremand et al., 2009; Petremand et al., 2012; Rutti et al., 2009) including TM, a N-glycosylation 
inhibitor [Figure 1A and (Petremand et al., 2009)]. To determine if the protection conferred by HDLs on 
TM-treated beta cells was associated with an inhibition of the mitochondrial apoptotic pathway, the Min6 
mouse beta cell line was incubated with TM in the presence or in the absence of HDLs. The extent of 
caspase-3 activation and Bax activation was then assessed. Figure 1B shows that HDLs inhibited TM- 
induced apoptosis in Min6 cells and that this correlated with a reduction in the cleavage of full-length 
caspase-3 into the active form of the protease. Moreover, HDLs hampered TM-induced Bax activation 
(Figure 1C). These results indicate that HDLs efficiently prevent TM-induced beta cell death most likely by 
antagonizing the intrinsic mitochondrial apoptotic death pathway. 
 
 
 
 
3.2. HDLs inhibit tunicamycin-induced ER morphological alterations 
 
 
HDLs allow beta cells to preserve their ER morphology in the presence of ER stressors such as palmitate 
and TG (Petremand et al., 2012). We therefore wished to determine if the protection conferred by 
HDLs against  TM-induced  beta  cells  death  was  also  associated  with  the  maintenance  of  a  
normal ER morphology. A 6 hour-incubation with TM induced a moderate ER ballooning but no obvious 
alterations of other organelles (Figure 2A). ER ballooning was more extensive when the cells were 
incubated with TM for 24 hours (Figure 2B) and this was associated with the appearance of DNA 
condensation typically seen in apoptotic cells (asterisks in Figure 2B). The ballooning stimulated by  
TM was markedly reduced by HDLs but not fully abolished (Figure 3). As reported earlier, HDLs  
totally prevented the strong ER ballooning induced by TG (Figure 3). Altogether, these results indicate 
that HDLs have a broad capacity to preserve ER morphology in the presence of various ER stressors. 
  
 
 
 
 
 
3.3. HDLs do not prevent tunicamycin-induced ER stress marker increase 
 
 
In beta cells, the ER stress response induced by TG, cyclopiazonic acid, and palmitate is efficiently 
inhibited by HDLs (Petremand et al., 2012). Specifically, in response to these agents, HDLs repressed 
XBP-1 splicing, CHOP and BiP induction, and PERK and JNK activation (Petremand et al., 2012) that are 
all markers of the unfolded protein response activated following ER stress (Hetz, 2012). It was therefore 
expected that the ability of HDLs to counteract TM-induced apoptosis in Min6 cells would also result in 
inhibition of ER stress response induction. This was, surprisingly, not the case: TM-induced XBP-1 
splicing was not altered by HDLs (Figure 4A and B). There was a trend of a slight decrease in BiP 
expression (Figure 4B), PERK activation (Figure 4C), and CHOP induction at the mRNA and protein levels 
(Figure 4D-E) but this did not reach statistical significance. These results indicate that HDLs can inhibit 
apoptosis of beta cells subjected to ER stress when several arms of the UPR are activated. 
 
 
 
 
3.4. HDLs do not restore ER protein folding and trafficking impaired by tunicamycin 
 
 
It was recently demonstrated that, in the presence of ER stressors, HDLs maintain the ER protein folding 
capacity of beta cells and allow protein trafficking from the ER to the plasma membrane via the Golgi 
(Petremand et al., 2012). To assess if HDLs have the same beneficial effect on the ER in TM-stimulated 
beta cells, we employed a fusion protein between the green fluorescence protein (GFP) and a 
temperature-sensitive mutant of the vesicular stomatitis virus G (VSVG) protein (Presley et al., 1997). This 
fusion protein traffics from the ER to the plasma membrane via the Golgi apparatus at the permissive 
temperature of 32°C. At 40°C degrees however, the fusion protein is misfolded and accumulates in the 
ER. Switching the temperature back to 32°C allows proper refolding of the VSVG-GFP fusion protein and 
resuming of the protein transport to the cell surface (Petremand et al., 2012; Presley et al., 1997). MIN6 
cells were infected with lentiviruses encoding the VSVG fusion protein. They were then treated with TM in 
the presence or in the absence of HDLs and incubated at 40°C for 5 hours. The block at 40°C, which 
impairs folding of the VSVG-GFP mutant, led to its accumulation in the ER (Figure 5, upper row). Cells 
  
 
 
were then incubated for 1 hour at 32°C to allow VSVG-GFP folding and trafficking to the membrane. In the 
control condition, after 1 hour at 32°C, VSV-G was correctly folded and was localized at the plasma 
membrane (Figure 5, second row from the top). However, in the presence of TM, VSV-G did not traffic to 
the membrane and the percentage of cells with folded VSV-G was strongly reduced compared to the 
control (Figure 5, third row from the top). HDLs were unable to reverse these defects (Figure 5, lower 
row), which mirrors their inability to prevent ER stress marker induction by TM (see Figure 4). 
 
 
 
 
3.4. Effects of HDL on ER stressor-induced Akt and JNK modulation 
 
 
In Min6 cells, TM and TG have been shown, on one hand, to reduce basal activation of Akt and, on the 
other hand, to stimulate the JNK MAPK pathway (Srinivasan et al., 2005). These effects could be 
mitigated by insulin-like growth factor 1 (IGF1) (Srinivasan et al., 2005). HDLs may have a similar effect, 
which could partly explain how they protect cells against TM-induced apoptosis despite their inability to 
restore ER functionality. We therefore tested the potential Akt and JNK modulatory role of HDLs in the 
presence of various ER stressors, including TM. Figure 6A shows that HDLs efficiently inhibited apoptosis 
of Min6 cells induced by TG, TM, inflammatory cytokines, and palmitate, compounds that have all shown 
to provoke ER stress (Kharroubi et al., 2004; Petremand et al., 2009). As reported (Srinivasan et al., 
2005), TG and TM decreased basal Akt activation (Figure 6B). HDLs significantly blunted this decrease. 
However, this dampening effect was rather weak when Min6 cells were treated with TG. Inflammatory 
cytokines and palmitate induced a marked activation of Akt that was not modulated by HDLs. There is 
therefore no clear correlation between Akt stimulation levels and beta cell protection. Possibly, Akt 
contributes to beta cell protection but by itself can apparently not induce efficient beta cell survival. 
 
JNKs were activated by TG and HDLs had a tendency to reduce this response but this did not reach 
statistical significance (Figure 6C). Inflammatory cytokines also stimulated the JNK MAPK pathway. 
However, this was not modulated by HDLs. TM and palmitate, in the conditions used here, did not 
stimulate the JNKs. These results indicate that inhibition of the JNK pathway is not a mechanism used by 
HDLs to protect beta cells. 
  
 
 
 
 
 
3.5. HDLs are protecting Min6 cells at submicromolar concentrations 
 
 
When addressing HDL functions in pancreatic cells, one needs to consider the concentrations that may be 
found outside the vascular system. Intuitively, it could be expected that HDL concentrations are low in the 
extravascular space. However, the available data indicate that the vascular and extra vascular HDL 
concentrations are not very much different. For example, the HDL concentrations in the lymph and in 
synovial fluid were measured to be 0.4 +/- 0.1 mM and 0.7 +/- 0.1 mM, respectively (Busso et al., 2001; 
Nanjee et al., 2001) which is not far away from the blood HDL concentrations (1-1.5 mM). This suggests 
an active transport of HDLs through the vasculature, the mechanism of which starts to be unraveled 
(Cavelier et al., 2012; Ohnsorg et al., 2011; Rohrer et al., 2009). To assess the physiological relevance of 
our results, we determined if HDLs in the concentration range found in extravascular tissues (0.4 to 0.7 
mM) can protect MIN6 cells. Figure 6 shows that HDLs can inhibit TM- and TG-induced MIN6 apoptosis at 
doses as low as 0.25 mM. This suggests that extravascular HDL levels can protect beta cells against ER 
stressors. 
  
 
 
 
 
4. Discussion 
 
 
The present work indicates that HDLs can protect pancreatic beta cells against TM-induced apoptosis 
despite the continuous activation of UPR pathways and impairment of the ER functionality (protein folding 
and trafficking). This contrasts with earlier data indicating that HDLs block TG-induced beta cell death by 
maintaining proper functioning of the ER (Petremand et al., 2012). HDLs have therefore at least two ways 
of protecting beta cells. They can prevent ER dysfunctions and the resulting stress response induced by 
drugs such as TG and pro-diabetogenic lipids such as palmitate. If this first line of defense cannot be 
established, such as when TM is used, HDLs can still protect beta cells downstream of ER stress 
response activation (Figure 8). 
 
It could be argued that HDLs can inhibit an ER stress response only if this stress response is not too 
strong. However, the activation of the ER stress pathway by TG and TM at the concentration used here 
(0.5 μM and 2 μg/ml, respectively) was found to be comparable when BiP expression is considered [see 
Figure 7 in (Petremand et al., 2009). This can also be seen by comparing Figure 4 of the present work 
with Figure 2 of reference (Petremand et al., 2012) that were both derived from the same set of data. For 
 
other stress markers like the induction of ATF4 [see Figure 7 in (Petremand et al., 2009)] or the induction 
of CHOP mRNA and protein levels [compare Figure 4 of the present work with Figure 2 of reference 
(Petremand et al., 2012)], 2 μg/ml of TM induced a weaker response compared to 0.5 μM TG. We also note 
that TG-induced ER ballooning was much more pronounced than when TM was employed (Figure 3). 
The extent of ER stress and UPR activation by TM does not therefore appear to be stronger than the  
one induced by TG, at least with the doses used in the present study, indicating that the ability of 
HDLs to inhibit UPR induction depends more on the nature of the ER stressors rather than the extent of 
the stress itself. 
 
It has to be pointed out however that the data shown in Figure 4 suggest that HDLs may lead to a 
partial, albeit non-significant, decrease in the induction of some ER stress markers, CHOP mRNA and  
protein levels in particular, but as detailed  in  the  previous  paragraph,  HDLs  were  clearly  less  
efficient  in diminishing the possibly weaker UPR activated by TM compared to the UPR induced by TG. 
  
 
 
There are precedents of beta cell protection against ER stressor-induced death in spite of continuous 
activation of the UPR. It was indeed reported that IGF-1 protects, or at least delays, TM-induced MIN6 cell 
apoptosis assessed by PARP cleavage even though TM-mediated CHOP induction was unaffected 
(Srinivasan et al., 2005). 
 
Decreased Akt stimulation often compromises beta cell survival (Li et al., 2005; Natalicchio et al., 2010; 
Storling et al., 2005; Yano et al., 2007) but this is not always the case. In mice expressing the 
myristoylated constitutive form of Akt (myr-Akt) specifically in insulin-producing cells, basal apoptosis in 
beta cells is increased by at least ten fold while streptozotocin-induced beta cell apoptosis is inhibited by 
~80% (Tuttle et al., 2001). The survival response after Akt activation in resting beta cells and stressed 
beta cells diverges therefore. Transfection of the INS1 insulinoma cell line with myr-Akt-encoding plasmids 
induces their death in an NFkB-dependent manner (Bulat et al., 2011) but infecting the same cell line with 
myr-Akt-encoding adenoviruses protects them against a cocktail of inflammatory cytokines (Li et al., 
2005). Possibly, theses opposite results originate from different Akt expression levels achieved by either 
transfection or infection. The role of Akt in the control of beta cell survival is therefore highly context- 
dependent, which presumably is at the basis of the apparent conflicting observations that Akt, depending 
on the experimental conditions, either promotes or inhibits apoptosis in beta cells. In the present study, 
Akt was activated by palmitate and inflammatory cytokines but this did not result in beta cell protection. An 
earlier study reported a palmitate-induced Akt activation in INS1 cells and this activation led to reduced 
viability and/or proliferation (Higa et al., 2006). Inflammatory cytokines (IL1β, IFNγ, with or without TNFα), on 
the other hand, are generally reported to induce decreased Akt activation (Li et al., 2005; Natalicchio et 
al., 2010) but the beta cell death induced by these cytokines may only partially results from Akt down- 
regulation (Li et al., 2005). The reason why an increased Akt activation following stimulation of Min6 cells 
was observed in the present study and not in others is unclear but may be related to the extent of the 
cellular stress experienced by the beta cells in the various experimental systems. The extent of cellular 
stress can be evaluated by the p120 RasGAP protein, a sensor of caspase-3 activity (Khalil et al., 
2012; Khalil et al., 2013). In response to weak stresses, caspase-3 activity raises in cells, but to minimal 
extent, and this results in the partial cleavage of RasGAP into an N-terminal fragment, called fragment N, 
that can protect cells by activating Akt (Yang et al., 2004). Fragment N can protect beta cells against a 
variety of 
pro-diabetogenic insults both in vitro and in vivo (Bulat et al., 2011; Yang et al., 2009; Yang et al., 2005). If 
 
 
the stress becomes too intense so as to become pro-apoptotic, fragment N is further cleaved by the now 
higher caspase-3 activity, abrogating its capacity to stimulate Akt (Yang et al., 2005). The sequential 
cleavage of RasGAP regulated by increasing caspase-3 activation can therefore determine whether a 
stressed cell survives or not (Khalil et al., 2013). However, there are stress-inducing factors that, despite 
allowing the formation of fragment N, cannot efficiently prevent further caspase-3 activation and apoptosis 
(Khalil et al., 2012). In such cases, Akt can nevertheless be activated but this is not counteracting 
apoptosis and may just represent a futile attempt of the cell to protect itself. Possibly, Akt activation by 
cytokines corresponds to a similar phenomenon. This could be tested by determining if inflammatory 
cytokine-induced Akt activation is prevented by caspase inhibitors. 
 
Inflammatory cytokines are well-known for their ability to activate the NFkB factor in pancreatic beta cells 
(Donath et al., 2008). Even though NFkB is usually considered a downstream effector of Akt (Salminen 
and Kaarniranta, 2010), it has been suggested that Akt in beta cells could be activated following NFkB 
stimulation in some situations (Storling et al., 2011). Whether cytokines have the potential to stimulate Akt 
via NFkB is therefore a possibility that could be experimentally addressed in the future. 
 
What prevents HDLs from inhibiting the induction of the UPR in response to stresses such as TM? Even if 
HDLs have an initial capacity to maintain the functionality of the ER in TM-treated cells, the inhibition of 
protein glycosylation by TM would anyway not permit proper protein trafficking and this would ultimately 
results in increased protein load and misfolding in the ER leading to augmented ER stress and ER 
malfunction. In contrast, TG does not directly affect ER-resident  proteins  but  rather  the  biophysical 
properties of the ER lumen by decreasing the ER calcium concentration (Sambrook, 1990). In this 
situation, HDL-mediated maintenance of ER functionality allows protein to fold and traffic properly hence 
reducing ER stress (Petremand et al., 2012). Palmitate also provokes a drop in ER calcium concentration 
in several cell types including pancreatic beta cells (Gwiazda et al., 2009; Wei et al., 2009). In this 
case too, HDLs allow proper protein trafficking and correct protein folding in the ER and this alleviates 
the ER stress that palmitate would otherwise stimulate (Petremand et al., 2012). Therefore, HDLs may 
not be able to prevent ER stress induced by drugs and conditions that directly alter proteins in a 
way that 
prevents them from folding and trafficking correctly. In contrast, HDLs can inhibit ER stress by maintaining 
 
 
the ER functionality in the presence of drugs and conditions that alter the bio-physical properties of the 
ER, but not directly the ER proteins. This model is consistent with the observation that over-expression of 
wild-type insulin in beta cells leads to an ER stress that can be inhibited by HDLs, while the ER stress 
induced by over-expression of the C96Y insulin mutant that does not fold properly cannot (Petremand et 
al., 2012). 
 
Interestingly, HDLs can prevent ER morphology alterations (i.e. ER ballooning) induced by both TG and 
TM. Since HDLs inhibit induction of the UPR by TG but not by TM, one can conclude that there is 
dissociation between ER ballooning and UPR. To our knowledge, the pathway leading to ER swelling or 
ballooning is not characterized yet. Our results indicate nevertheless that this uncharacterized ER stress- 
induced pathway involve proteins or lipids that can be targeted by HDLs. 
 
The nature of the signaling pathways activated by HDLs that on one hand favor ER functions (e.g. in the 
presence of TG) and on the other hand protects beta cells despite the presence of an ER stress (e.g. in 
the presence of TM) currently remain a mystery. Identification of these pathways is of clear clinical 
importance as this is a pre-requisite for the development of drugs that stimulate or mimic the anti-
diabetic effects of HDLs to lower the risk, for example in overweight patients, of developing type 2 
diabetes. 
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Figure legends 
 
 
 
 
 
Figure 1: HDLs protect beta cells against TM-induced apoptosis 
 
 
A: MIN6 cells were treated with 2 μg/ml TM for 24 hours or left untreated (C) in the presence or in the 
absence of 1 mM HDLs and apoptosis was assessed by scoring pycnotic nucleus. Results correspond to 
the mean ± 95% CI of 6 independent experiments. Asterisks denote statistically significant difference 
between the indicated conditions as assessed by paired t-test with Bonferroni corrections. B: Alternatively, 
protein extracts were prepared and the active form of Bax was immunoprecipitated. Western blot against 
Bax was then performed. #, unspecific band. This experiment was repeated twice and yielded identical 
results. 
 
 
Figure 2: HDL effect on TM-induced ER morphology alterations 
 
Representative electron micrographs showing MIN6 cells (low magnification) and ER morphology (high 
magnification) following treatments with the indicated compounds for 6 hours (panel A) or 24 hours (panel 
B). Note the ballooning of the ER in TM-treated cells. TM, tunicamycin; N, nucleus; the asterisks indicate 
DNA condensation. 
 
 
Figure 3: Comparison of the HDL protective effect against ER morphology alterations induced by 
tunicamycin and thapsigargin 
Representative electron micrographs showing the ER morphology of MIN6 cells stimulated as in Figure 2A 
(top) and corresponding quantitation of the ER thickness (bottom). ER thickness was evaluated by 
calculating the area/Feret diameter of individual ER segments of at least 50 cells per condition (see 
Material and methods). Asterisks over individual bars indicate a statistically significant difference with the 
control condition. The asterisks over horizontal lines indicate a statistically significant difference with the 
two indicated conditions. Ctrl, control; TM, tunicamycin; TG, thapsigargin (0.5 μM); N, nucleus. 
  
 
 
Figure 4: TM-induced ER stress marker induction is not blocked by HDLs 
 
A. MIN6 cells were left untreated (C) or treated with 2 µg/ml TM during 6 hours (panels A, C and D) or 24 
hours (panels B and E) in the presence or in the absence of 1 mM HDLs. The cells were then lysed and 
RNA and proteins were isolated. The extent of XBP1 mRNA splicing was then determined (panel A). The 
pound sign indicates an unspecific band (Petremand et al., 2012). Western blot analyses were performed 
to assess protein expression of BiP (panel B), phospho-PERK (panel C), and CHOP (panel E). CHOP 
mRNA expression was determined by quantitative PCR (panel D). The results shown in panels A to E are 
derived from 4, 6, 4, 6, and 5 independent experiments, respectively. Asterisks denote statistically 
significant difference between the indicated conditions; NS, not significant. 
 
 
Figure 5: HDLs do not restore TM-induced folding and trafficking impairment 
 
MIN6 cells were infected with VSVG-GFP-encoding lentiviruses and treated two days later with or without 
2 μg/ml TM in the presence or in the absence of 1 mM HDLs for 5 hours at 40°C. The cells were then 
incubated or not for an additional 1 hour time period at 32°C. Immuno-cytochemistry was performed on 
non-permeabilized cells using an antibody directed against the ectopic part of VSVG (left-hand side of the 
figure) and on permeabilized cells using an antibody recognizing the correctly folded form of the protein 
(right-hand side of the figure). The percentage of cells expressing cell surface or folded VSVG was 
quantitated and shown in the bar graphs (4 independent experiments). Asterisks denote statistically 
significant difference between the indicated conditions; NS, not significant. 
 
 
Figure 6: Effect of HDLs on Akt and JNK activity in the presence of various ER stressors 
 
MIN6 cells were left untreated (Ctrl) or stimulated with 0.5 μM TG for 6 hours, 2 μg/ml TM for 12 hours, a 
cocktail of inflammatory cytokines (IL1β, IFNγ, and TNFα; each at a 1’000 U/ml concentration) for 8 hours, 
and 0.3 mM palmitate/0.5% BSA for 24 hours, in the presence or in the absence of 1 mM HDL. A. 
Apoptosis was then measured by scoring the percentage of cells with pycnotic or fragmented nucleus. B- 
 
C. Alternatively, the cells were lysed and activation of Akt (panel B) and JNK (panel C) was assessed by 
Western blotting using an antibody recognizing Akt phosphorylated on serine 473 and an antibody specific 
for the active phosphorylated forms of JNKs. The blots were reprobed with antibodies recognizing total Akt 
and total JNK. The intensities of the phosphorylated bands were normalized against those of total Akt and 
 
 
total JNK and further normalized to the control condition. The results are derived from 3-6 independent 
experiments. Asterisks indicate a statistically significant difference between the indicated conditions. 
 
 
Figure 7: HDLs protect Min6 cells at sub-micromolar concentrations 
 
MIN6 cells were left untreated (Ctrl), incubated with 1 mM HDL, or stimulated with 2 μg/ml TM or 0.5 μM TG 
in the presence of increasing concentrations of HDLs. Apoptosis was then measured 24 hours later by 
scoring  the  percentage  of  cells  with  pycnotic  or  fragmented  nucleus  (3  independent  experiments). 
 
Asterisks indicate a statistically significant difference between apoptosis induced by TM or TG alone and 
the indicated conditions. 
 
 
Figure 8: HDLs protect beta cells at several levels along ER stress-mediated apoptosis pathways 
HDLs have the capacity to preserve the morphology of the ER in presence of various ER stressors. In 
some cases (TG, palmitate), this is associated with a maintenance of ER functionality (protein folding, 
protein trafficking through the ER), which is required for the ability of HDLs to blunt the UPR and to 
efficiently protect the beta cells (Petremand et al., 2012). In other cases (TM), preservation of the ER 
morphology  is  not  associated  with  maintenance  of  the  ER  functionality  and  inhibition  of  the  UPR. 
Nevertheless, in these situations, HDLs can still inhibit apoptosis downstream of the UPR (present study). 
Therefore HDLs have the capacity to activate several, apparently non-redundant, anti-apoptotic pathways 
in beta cells, which might explain their ability to protect beta cells in response to a variety of insults. 
  
  
  
  
  
  
  
  
